All terms in CHEBI
| Label | Id | Description |
|---|---|---|
| mannosylinositol phosphophytoceramide | CHEBI_65000 | [A mannosylinositol phosphorylceramide in which the ceramide portion consists of a phytoceramide. As with other ceramide derivatives, The R substituents vary with different phytosphingoid bases and fatty acyl moieties.] |
| Man-1-2-Ins-1-P-Cer(t20:0)(1-) | CHEBI_138892 | [A mannosylinositol phosphorylceramide(1-) having an acyl group attached to the ceramide nitrogen and hydroxylation at C4 of the C20 sphingoid base; major species at pH 7.3.] |
| 6-O-(beta-D-xylopyranosyl)-beta-D-glucopyranose | CHEBI_16405 | |
| 6-hydroxy-2,6-dimethyl-2,7-octadien-1-yl D-glucopyranoside | CHEBI_139437 | |
| 5'-acylphosphoadenosine | CHEBI_16406 | |
| 5'-acylphosphoadenosine(1-) | CHEBI_60043 | [The conjugate base of a 5'-acylphosphoadenosine; major species at pH 7.3.] |
| 1,3,5-trihydroxy-4-{[(2E)-3-(3-hydroxy-4-methoxyphenyl)-2-propenoyl]oxy}cyclohexanecarboxylic acid | CHEBI_139438 | |
| hexyl 6-O-pentopyranosylhexopyranoside | CHEBI_139439 | |
| vomilenine | CHEBI_16408 | [An indole alkaloid that is vinorine bearing a hydroxy substituent at position 21.] |
| hemiaminal | CHEBI_73080 | [Any organic amino compound that has an amino group and a hydroxy group attached to the same carbon atom. Hemiaminals are intermediates in the formation of imines by addition of an amine to an aldehyde or ketone; those derived from primary amines are particularly unstable.] |
| alpha-N-peptidyl-L-glutamate | CHEBI_16401 | |
| peptidyl-glutamate | CHEBI_25918 | |
| beta-D-mannosyl decaprenyl phosphate | CHEBI_16402 | |
| 3-oxoglycyrrhetinic acid | CHEBI_16404 | |
| 3-oxoglycyrrhetinate | CHEBI_57760 | [The conjugate base of 3-oxoglycyrrhetinic acid acid; major species at pH 7.3.] |
| glycyrrhetinic acid | CHEBI_30853 | [A pentacyclic triterpenoid that is olean-12-ene substituted by a hydroxy group at position 3, an oxo group at position 11 and a carboxy group at position 30.] |
| granisetron | CHEBI_5537 | [A monocarboxylic acid amide resulting from the formal condensation of the carboxy group of 1-methyl-1H-indazole-3-carboxylic acid with the primary amino group of (3-endo)-9-methyl-9-azabicyclo[3.3.1]nonan-3-amine. A selective 5-HT3 receptor antagonist, it is used (generally as the monohydrochloride salt) to manage nausea and vomiting caused by cancer chemotherapy and radiotherapy, and to prevent and treat postoperative nausea and vomiting.] |
| Granisetron hydrochloride | CHEBI_5538 | |
| Graphinone | CHEBI_5539 | |
| granaticin | CHEBI_5533 |